Search

Author/Creator Chuang, W.‐L.

1. Alisporivir with peginterferon/ribavirin in patients with chronic hepatitis C genotype 1 infection who failed to respond to or relapsed after prior interferon‐based therapy: FUNDAMENTAL, a Phase II trial. Issue 7 (21st November 2014)

Authors:
Buti, M.; Flisiak, R.; Kao, J.‐H.; Chuang, W.‐L.; Streinu‐Cercel, A.; Tabak, F.; Calistru, P.; Goeser, T.; Rasenack, J.; Horban, A.; Davis, G. L.; Alberti, A.; Mazzella, G.; Pol, S.; Orsenigo, R.; Brass, C.
Journal:
Journal of viral hepatitis
Issue:
Volume 22:Issue 7(2015)
Page Start:
596
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Anti‐viral therapy is associated with improved survival but is underutilised in patients with hepatitis B virus‐related hepatocellular carcinoma: real‐world east and west experience. Issue 1 (24th May 2018)

Authors:
Chen, V. L.; Yeh, M.‐L.; Le, A. K.; Jun, M.; Saeed, W. K.; Yang, J. D.; Huang, C.‐F.; Lee, H. Y.; Tsai, P.‐C.; Lee, M.‐H.; Giama, N.; Kim, N. G.; Nguyen, P. P.; Dang, H.; Ali, H. A.; Zhang, N.; Huang, J.‐F.; Dai, C.‐Y.; Chuang, W.‐L.; Roberts, L. R.
Journal:
Alimentary pharmacology & therapeutics
Issue:
Volume 48:Issue 1(2018)
Page Start:
44
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Decline in pulmonary function during chronic hepatitis C virus therapy with modified interferon alfa and ribavirin. Issue 4 (14th February 2013)

Authors:
Foster, G. R.; Zeuzem, S.; Pianko, S.; Sarin, S. K.; Piratvisuth, T.; Shah, S.; Andreone, P.; Sood, A.; Chuang, W.‐L.; Lee, C.‐M.; George, J.; Gould, M.; Flisiak, R.; Jacobson, I. M.; Komolmit, P.; Thongsawat, S.; Tanwandee, T.; Rasenack, J.; Sola, R.; Messina, I.
Journal:
Journal of viral hepatitis
Issue:
Volume 20:Issue 4(2013)
Page Start:
e115
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. Hepatitis C transmission from viremic donors in hematopoietic stem cell transplant. Issue 6 (4th November 2014)

Authors:
Hsiao, H.‐H.; Liu, Y.‐C.; Wang, H.‐C.; Wu, C.‐H.; Cho, S.‐F.; Hsu, J.‐F.; Tsai, H.‐J.; Hsiao, S.Y.; Chang, C.‐S.; Lin, S.‐F.; Liu, T.‐C.; Chuang, W.‐L.; Yu, M.‐L.
Journal:
Transplant infectious disease
Issue:
Volume 16:Issue 6(2014)
Page Start:
1003
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. Predictors of response to tenofovir disoproxil fumarate plus peginterferon alfa‐2a combination therapy for chronic hepatitis B. Issue 9 (15th September 2016)

Authors:
Marcellin, P.; Ahn, S. H.; Chuang, W.‐L.; Hui, A. J.; Tabak, F.; Mehta, R.; Petersen, J.; Lee, C.‐M.; Ma, X.; Caruntu, F. A.; Tak, W. Y.; Elkhashab, M.; Lin, L.; Wu, G.; Martins, E. B; Charuworn, P.; Yee, L. J.; Lim, S. G.; Foster, G. R.; Fung, S.
Journal:
Alimentary pharmacology & therapeutics
Issue:
Volume 44:Issue 9(2016)
Page Start:
957
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. Responses are durable for up to 5 years after completion of peginterferon alfa‐2a treatment in hepatitis B e antigen‐positive patients. Issue 9 (9th March 2018)

Authors:
Chuang, W.‐L.; Jia, J.; Chan, H. L. Y.; Han, K.‐H.; Tanwandee, T.; Tan, D.; Chen, X.; Gane, E.; Piratvisuth, T.; Chen, L.; Xie, Q.; Sung, J. J.‐Y.; Messinger, D.; Wat, C.; Bakalos, G.; Liaw, Y. F.
Journal:
Alimentary pharmacology & therapeutics
Issue:
Volume 47:Issue 9(2018)
Page Start:
1306
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗